Melanoma vaccine - MedVac
Latest Information Update: 23 Sep 2021
Price :
$50 *
At a glance
- Originator New York University School of Medicine
- Developer MedVac; New York University School of Medicine
- Class Cancer vaccines
- Mechanism of Action Immunostimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malignant melanoma